Gluz O, Nitz U, Kolberg-Liedtke C, Prat A, et al. De-escalated neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Impact of molecular markers and survival analysis of the WSG-ADAPT-TN trial. Clin Cancer Res 2022 Jul 7. pii: 706903. doi: 10.1158/1078-0432.CCR-22-0482.
PMID: 35797219